# Oramed Pharmaceuticals Inc.: Form 8-K, filed Sep 26, 2023

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 8-K
- Filed: 2023-09-26
- Accepted by EDGAR: Sep 26, 2023, 16:34 ET
- Period: 2023-09-21
- Accession: 0001213900-23-079586
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390023079586/ea185680-8k_oramedpharma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390023079586/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390023079586/ea185680-8k_oramedpharma.htm

Filed Sep 26, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-079586. Last ingested by Listed: Nov 15, 2026, 04:14 ET. No prices; not investment advice.
